Risk factor management matters more than pharmaceutical cyclooxygenase-2 inhibition in the prevention of de novo intracranial aneurysms.
Sari RäisänenJukka HuttunenTerhi J HuuskonenMikael von Und Zu FraunbergTimo KoivistoJuha E JääskeläinenAntti E LindgrenJuhana FrösenPublished in: European journal of neurology (2022)
For the prevention of de novo sIA formation, risk factor management with focus on cessation of smoking and treating hypertension adequately seems more important than pharmaceutical COX-2 inhibition.